317 related articles for article (PubMed ID: 21536666)
1. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.
Farris SD; Hu JH; Krishnan R; Emery I; Chu T; Du L; Kremen M; Dichek HL; Gold E; Ramsey SA; Dichek DA
J Biol Chem; 2011 Jun; 286(25):22665-77. PubMed ID: 21536666
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.
Kremen M; Krishnan R; Emery I; Hu JH; Slezicki KI; Wu A; Qian K; Du L; Plawman A; Stempien-Otero A; Dichek DA
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17109-14. PubMed ID: 18957535
[TBL] [Abstract][Full Text] [Related]
3. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.
Hu JH; Touch P; Zhang J; Wei H; Liu S; Lund IK; Høyer-Hansen G; Dichek DA
Cardiovasc Res; 2015 Mar; 105(3):372-82. PubMed ID: 25616415
[TBL] [Abstract][Full Text] [Related]
4. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.
Lugano R; Peña E; Badimon L; Padró T
J Thromb Haemost; 2012 Oct; 10(10):2158-67. PubMed ID: 22906080
[TBL] [Abstract][Full Text] [Related]
5. Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.
Cunningham O; Campion S; Perry VH; Murray C; Sidenius N; Docagne F; Cunningham C
Glia; 2009 Dec; 57(16):1802-14. PubMed ID: 19459212
[TBL] [Abstract][Full Text] [Related]
6. Level of macrophage uPA expression is an important determinant of atherosclerotic lesion growth in Apoe-/- mice.
Krishnan R; Kremen M; Hu JH; Emery I; Farris SD; Slezicki KI; Chu T; Du L; Dichek HL; Dichek DA
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1737-44. PubMed ID: 19729604
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions.
Steins MB; Padró T; Schwaenen C; Ruiz S; Mesters RM; Berdel WE; Kienast J
Blood Coagul Fibrinolysis; 2004 Jul; 15(5):383-91. PubMed ID: 15205586
[TBL] [Abstract][Full Text] [Related]
9. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
Zhang J; Sud S; Mizutani K; Gyetko MR; Pienta KJ
Neoplasia; 2011 Jan; 13(1):23-30. PubMed ID: 21245937
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway.
Oka H; Kugiyama K; Doi H; Matsumura T; Shibata H; Miles LA; Sugiyama S; Yasue H
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):244-50. PubMed ID: 10634825
[TBL] [Abstract][Full Text] [Related]
11. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms.
Uchida HA; Poduri A; Subramanian V; Cassis LA; Daugherty A
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2845-52. PubMed ID: 21868698
[TBL] [Abstract][Full Text] [Related]
13. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
14. Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation.
Connolly BM; Choi EY; Gårdsvoll H; Bey AL; Currie BM; Chavakis T; Liu S; Molinolo A; Ploug M; Leppla SH; Bugge TH
Blood; 2010 Sep; 116(9):1593-603. PubMed ID: 20466854
[TBL] [Abstract][Full Text] [Related]
15. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
[TBL] [Abstract][Full Text] [Related]
16. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
[TBL] [Abstract][Full Text] [Related]
17. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
19. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
20. [Expression of urokinase plasminogen activator, its receptor and plasminogen activator inhibitor type 1 in different types of atherosclerotic lesion in human aorta].
Solomatina MA; Plekhanova OS; Il'inskaia OP; Kalinina NI; Mikhaĭlova EV; Tsokolaeva ZI; Tararak EM; Naumov VG; Parfenova EV
Tsitologiia; 2004; 46(4):352-60. PubMed ID: 15346794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
